HEADER APOPTOSIS/INHIBITOR 20-SEP-11 4A1W TITLE CRYSTAL STRUCTURE OF ALPHA-BETA FOLDAMER 4C IN COMPLEX WITH BCL-XL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-2-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ALPHA-BETA-FOLDAMER 2C; COMPND 8 CHAIN: P, Q, R, S; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 13 ORGANISM_TAXID: 32630 KEYWDS APOPTOSIS-INHIBITOR COMPLEX, MIMICRY EXPDTA X-RAY DIFFRACTION AUTHOR M.D.BOERSMA,H.S.HAASE,K.J.KAUFMAN,W.S.HORNE,E.F.LEE,O.B.CLARKE, AUTHOR 2 B.J.SMITH,P.M.COLMAN,S.H.GELLMAN,W.D.FAIRLIE REVDAT 7 20-DEC-23 4A1W 1 REMARK REVDAT 6 15-NOV-23 4A1W 1 REMARK LINK ATOM REVDAT 5 10-JUL-19 4A1W 1 REMARK REVDAT 4 24-APR-19 4A1W 1 REMARK SEQRES REVDAT 3 20-JUN-18 4A1W 1 REMARK LINK REVDAT 2 25-JAN-12 4A1W 1 JRNL REVDAT 1 28-DEC-11 4A1W 0 JRNL AUTH M.D.BOERSMA,H.S.HAASE,K.J.PETERSON-KAUFMAN,E.F.LEE, JRNL AUTH 2 O.B.CLARKE,P.M.COLMAN,B.J.SMITH,W.S.HORNE,W.D.FAIRLIE, JRNL AUTH 3 S.H.GELLMAN JRNL TITL EVALUATION OF DIVERSE ALPHA/BETA-BACKBONE PATTERNS FOR JRNL TITL 2 FUNCTIONAL ALPHA-HELIX MIMICRY: ANALOGUES OF THE BIM BH3 JRNL TITL 3 DOMAIN. JRNL REF J.AM.CHEM.SOC. V. 134 315 2012 JRNL REFN ISSN 0002-7863 JRNL PMID 22040025 JRNL DOI 10.1021/JA207148M REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 30333 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1522 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 64.0479 - 5.5515 0.99 2795 147 0.2005 0.2256 REMARK 3 2 5.5515 - 4.4067 1.00 2681 141 0.1582 0.2307 REMARK 3 3 4.4067 - 3.8498 1.00 2653 140 0.1551 0.2233 REMARK 3 4 3.8498 - 3.4978 1.00 2616 138 0.1877 0.2369 REMARK 3 5 3.4978 - 3.2471 1.00 2631 138 0.2120 0.2926 REMARK 3 6 3.2471 - 3.0557 1.00 2592 136 0.2023 0.2766 REMARK 3 7 3.0557 - 2.9026 1.00 2626 140 0.2076 0.3353 REMARK 3 8 2.9026 - 2.7763 1.00 2583 136 0.2295 0.3313 REMARK 3 9 2.7763 - 2.6694 1.00 2590 138 0.2537 0.2958 REMARK 3 10 2.6694 - 2.5773 1.00 2591 137 0.2585 0.3447 REMARK 3 11 2.5773 - 2.4967 0.94 2453 131 0.2785 0.3538 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 42.10 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.850 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.890 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.99200 REMARK 3 B22 (A**2) : -9.63460 REMARK 3 B33 (A**2) : -8.35750 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5386 REMARK 3 ANGLE : 1.155 7291 REMARK 3 CHIRALITY : 0.082 745 REMARK 3 PLANARITY : 0.004 938 REMARK 3 DIHEDRAL : 18.103 1972 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4A1W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1290048911. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95373 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30333 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.550 REMARK 200 R MERGE (I) : 0.18000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.9900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.55 REMARK 200 R MERGE FOR SHELL (I) : 0.92000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.170 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3FDL REMARK 200 REMARK 200 REMARK: MOLECULAR REPLACEMENT WAS PERFORMED USING THE STRUCTURE OF REMARK 200 BCL-XL FROM THE PDB ENTRY 3FDL, WITH THE PEPTIDE REMOVED, AS A REMARK 200 SEARCH MODEL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG 3350, 0.2 M LITHIUM REMARK 280 SULFATE, 0.1 M HEPES PH 7.5. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 40.10650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.14500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.10650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.14500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, P, S REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, Q, R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2001 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ALPHA-BETA-FOLDAMER 2C IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ALPHA-BETA-FOLDAMER 2C REMARK 400 CHAIN: P, Q, R, S REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 ASN A 198 REMARK 465 ALA A 199 REMARK 465 ALA A 200 REMARK 465 ALA A 201 REMARK 465 GLU A 202 REMARK 465 SER A 203 REMARK 465 ARG A 204 REMARK 465 LYS A 205 REMARK 465 GLY A 206 REMARK 465 GLN A 207 REMARK 465 GLU A 208 REMARK 465 ARG A 209 REMARK 465 GLY B -4 REMARK 465 PRO B -3 REMARK 465 ASN B 198 REMARK 465 ALA B 199 REMARK 465 ALA B 200 REMARK 465 ALA B 201 REMARK 465 GLU B 202 REMARK 465 SER B 203 REMARK 465 ARG B 204 REMARK 465 LYS B 205 REMARK 465 GLY B 206 REMARK 465 GLN B 207 REMARK 465 GLU B 208 REMARK 465 ARG B 209 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 LEU C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 ASN C 197 REMARK 465 ASN C 198 REMARK 465 ALA C 199 REMARK 465 ALA C 200 REMARK 465 ALA C 201 REMARK 465 GLU C 202 REMARK 465 SER C 203 REMARK 465 ARG C 204 REMARK 465 LYS C 205 REMARK 465 GLY C 206 REMARK 465 GLN C 207 REMARK 465 GLU C 208 REMARK 465 ARG C 209 REMARK 465 GLY D -4 REMARK 465 PRO D -3 REMARK 465 LEU D -2 REMARK 465 GLY D -1 REMARK 465 ASN D 197 REMARK 465 ASN D 198 REMARK 465 ALA D 199 REMARK 465 ALA D 200 REMARK 465 ALA D 201 REMARK 465 GLU D 202 REMARK 465 SER D 203 REMARK 465 ARG D 204 REMARK 465 LYS D 205 REMARK 465 GLY D 206 REMARK 465 GLN D 207 REMARK 465 GLU D 208 REMARK 465 ARG D 209 REMARK 465 ILE P 206 REMARK 465 ILE R 206 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CG SD CE REMARK 470 ASN A 197 CG OD1 ND2 REMARK 470 SER D 0 OG REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 7 OE1 OE2 REMARK 480 GLN A 26 CD REMARK 480 ASP A 107 CB CG OD1 OD2 REMARK 480 GLN A 160 CG CD OE1 NE2 REMARK 480 GLU A 193 CG CD OE1 OE2 REMARK 480 ARG B 6 CG CD NE CZ NH1 NH2 REMARK 480 GLN B 26 CG CD OE1 NE2 REMARK 480 ASP B 107 CG OD1 OD2 REMARK 480 ASP B 133 CG OD1 OD2 REMARK 480 GLN B 183 CD OE1 NE2 REMARK 480 GLU B 184 CG CD OE1 OE2 REMARK 480 ASP B 189 OD1 OD2 REMARK 480 GLU B 193 CG CD OE1 OE2 REMARK 480 ASN B 197 O CB CG OD1 ND2 REMARK 480 GLN C 26 CG CD OE1 NE2 REMARK 480 ARG C 102 CG CD NE CZ NH1 NH2 REMARK 480 ASP C 107 CB CG OD1 OD2 REMARK 480 SER C 110 CB OG REMARK 480 GLN C 111 CG CD OE1 NE2 REMARK 480 GLN C 160 CD OE1 NE2 REMARK 480 GLN C 183 NE2 REMARK 480 GLU C 193 CG CD OE1 OE2 REMARK 480 MET D 1 CG SD CE REMARK 480 GLN D 3 CB CG CD OE1 NE2 REMARK 480 ARG D 6 CG CD NE CZ NH1 NH2 REMARK 480 GLU D 7 CD OE1 OE2 REMARK 480 ARG D 102 CD NE CZ NH1 NH2 REMARK 480 GLN D 121 CG CD OE1 NE2 REMARK 480 ARG D 132 NE CZ NH1 NH2 REMARK 480 ASN D 175 OD1 ND2 REMARK 480 GLN D 183 CD OE1 NE2 REMARK 480 GLU D 193 CG CD OE1 OE2 REMARK 480 TYR Q 222 OH REMARK 480 ILE S 206 N REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 156 OH TYR C 22 2.17 REMARK 500 O HOH A 2040 O HOH Q 2010 2.19 REMARK 500 O HOH C 2015 O HOH C 2016 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 B3E P 211 C - N - CA ANGL. DEV. = -18.1 DEGREES REMARK 500 B3Y Q 223 CA - C - N ANGL. DEV. = -21.4 DEGREES REMARK 500 B3E R 211 C - N - CA ANGL. DEV. = -15.5 DEGREES REMARK 500 B3Y S 223 CA - C - N ANGL. DEV. = -32.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 106 -99.90 30.25 REMARK 500 GLN A 111 -17.27 -45.21 REMARK 500 HIS A 113 83.74 67.70 REMARK 500 MET B 1 -112.93 -88.79 REMARK 500 ARG B 102 -64.80 -19.66 REMARK 500 SER C 4 100.85 141.33 REMARK 500 SER C 106 -79.70 -49.77 REMARK 500 PHE D 105 39.39 -141.03 REMARK 500 MET D 159 51.74 -118.46 REMARK 500 BIL P 215 -90.36 -2.67 REMARK 500 BIL Q 215 -73.34 -31.34 REMARK 500 BIL R 215 -88.10 2.03 REMARK 500 HT7 S 207 -87.18 -84.78 REMARK 500 HT7 S 207 -90.05 -81.96 REMARK 500 BIL S 215 -64.49 -21.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 B3E P 211 LEU P 212 147.79 REMARK 500 ARG P 214 BIL P 215 133.60 REMARK 500 3FB P 219 ASN P 220 146.59 REMARK 500 ARG Q 214 BIL Q 215 140.09 REMARK 500 3FB Q 219 ASN Q 220 145.73 REMARK 500 ARG R 214 BIL R 215 135.92 REMARK 500 3FB R 219 ASN R 220 146.95 REMARK 500 B3E S 211 LEU S 212 146.70 REMARK 500 ARG S 214 BIL S 215 137.12 REMARK 500 3FB S 219 ASN S 220 148.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 B3E P 211 -18.84 REMARK 500 3FB P 219 -16.55 REMARK 500 B3E Q 211 -17.03 REMARK 500 3FB Q 219 -18.69 REMARK 500 B3E R 211 -17.90 REMARK 500 3FB R 219 -16.70 REMARK 500 B3E S 211 -17.85 REMARK 500 3FB S 219 -16.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 AMIDE (NH2): TERMINAL AMIDE REMARK 600 3-AMINO-4-(P-TOLYL)BUTANOIC ACID (BTY): BETA PEPTIDE REMARK 600 3-AMINO-4-METHYLHEXANOIC ACID (BIL): BETA PEPTIDE REMARK 600 3-AMINO-4-PHENYLBUTANOIC ACID (BFE): BETA PEPTIDE REMARK 600 3-AMINO-4-(1H-INDOL-3-YL)BUTANOIC ACID (W3B): BETA PEPTIDE REMARK 600 3-AMINOPROPANOIC ACID (BGL): BETA PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4A1U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALPHA-BETA-FOLDAMER 2C IN COMPLEX WITH BCL-XL REMARK 999 REMARK 999 SEQUENCE REMARK 999 DELETION OF AMINO ACID RESIDUES 27-82 AND 210-233. DBREF 4A1W A 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4A1W A 83 209 UNP Q07817 B2CL1_HUMAN 83 209 DBREF 4A1W B 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4A1W B 83 209 UNP Q07817 B2CL1_HUMAN 83 209 DBREF 4A1W C 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4A1W C 83 209 UNP Q07817 B2CL1_HUMAN 83 209 DBREF 4A1W D 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4A1W D 83 209 UNP Q07817 B2CL1_HUMAN 83 209 DBREF 4A1W P 206 224 PDB 4A1W 4A1W 206 224 DBREF 4A1W Q 206 224 PDB 4A1W 4A1W 206 224 DBREF 4A1W R 206 224 PDB 4A1W 4A1W 206 224 DBREF 4A1W S 206 224 PDB 4A1W 4A1W 206 224 SEQRES 1 A 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 A 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 A 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 A 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 A 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 A 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 A 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 A 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 A 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 A 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 A 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 A 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 A 158 GLU ARG SEQRES 1 B 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 B 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 B 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 B 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 B 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 B 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 B 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 B 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 B 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 B 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 B 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 B 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 B 158 GLU ARG SEQRES 1 C 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 C 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 C 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 C 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 C 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 C 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 C 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 C 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 C 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 C 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 C 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 C 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 C 158 GLU ARG SEQRES 1 D 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 D 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 D 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 D 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 D 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 D 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 D 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 D 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 D 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 D 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 D 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 D 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 D 158 GLU ARG SEQRES 1 P 19 ILE HT7 ILE ALA GLN B3E LEU ARG ARG BIL GLY ASP GLU SEQRES 2 P 19 3FB ASN ALA TYR B3Y NH2 SEQRES 1 Q 19 ILE HT7 ILE ALA GLN B3E LEU ARG ARG BIL GLY ASP GLU SEQRES 2 Q 19 3FB ASN ALA TYR B3Y NH2 SEQRES 1 R 19 ILE HT7 ILE ALA GLN B3E LEU ARG ARG BIL GLY ASP GLU SEQRES 2 R 19 3FB ASN ALA TYR B3Y NH2 SEQRES 1 S 19 ILE HT7 ILE ALA GLN B3E LEU ARG ARG BIL GLY ASP GLU SEQRES 2 S 19 3FB ASN ALA TYR B3Y NH2 MODRES 4A1W HT7 P 207 TRP MODRES 4A1W B3E P 211 GLU (3S)-3-AMINOHEXANEDIOIC ACID MODRES 4A1W B3Y P 223 TYR MODRES 4A1W HT7 Q 207 TRP MODRES 4A1W B3E Q 211 GLU (3S)-3-AMINOHEXANEDIOIC ACID MODRES 4A1W B3Y Q 223 TYR MODRES 4A1W HT7 R 207 TRP MODRES 4A1W B3E R 211 GLU (3S)-3-AMINOHEXANEDIOIC ACID MODRES 4A1W B3Y R 223 TYR MODRES 4A1W HT7 S 207 TRP MODRES 4A1W B3E S 211 GLU (3S)-3-AMINOHEXANEDIOIC ACID MODRES 4A1W B3Y S 223 TYR HET HT7 P 207 27 HET B3E P 211 10 HET BIL P 215 9 HET 3FB P 219 12 HET B3Y P 223 13 HET NH2 P 224 1 HET HT7 Q 207 15 HET B3E Q 211 10 HET BIL Q 215 9 HET 3FB Q 219 12 HET B3Y Q 223 13 HET NH2 Q 224 1 HET HT7 R 207 27 HET B3E R 211 10 HET BIL R 215 9 HET 3FB R 219 12 HET B3Y R 223 13 HET NH2 R 224 1 HET HT7 S 207 27 HET B3E S 211 10 HET BIL S 215 9 HET 3FB S 219 12 HET B3Y S 223 13 HET NH2 S 224 1 HETNAM HT7 (3S)-3-AMINO-4-(1H-INDOL-3-YL)BUTANOIC ACID HETNAM B3E (3S)-3-AMINOHEXANEDIOIC ACID HETNAM BIL (3R,4S)-3-AMINO-4-METHYLHEXANOIC ACID HETNAM 3FB (3S)-3-AMINO-4-PHENYLBUTANOIC ACID HETNAM B3Y (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID HETNAM NH2 AMINO GROUP HETSYN HT7 BETA-HOMOTRYPTOPHAN HETSYN BIL (R,S)-BETA-3-HOMOISOLEUCINE FORMUL 5 HT7 4(C12 H14 N2 O2) FORMUL 5 B3E 4(C6 H11 N O4) FORMUL 5 BIL 4(C7 H15 N O2) FORMUL 5 3FB 4(C10 H13 N O2) FORMUL 5 B3Y 4(C10 H13 N O3) FORMUL 5 NH2 4(H2 N) FORMUL 9 HOH *256(H2 O) HELIX 1 1 MET A 1 GLN A 19 1 19 HELIX 2 2 SER A 25 ARG A 102 1 22 HELIX 3 3 ARG A 103 SER A 106 5 4 HELIX 4 4 THR A 109 HIS A 113 5 5 HELIX 5 5 THR A 118 PHE A 131 1 14 HELIX 6 6 ASN A 136 LYS A 157 1 22 HELIX 7 7 VAL A 161 LEU A 178 1 18 HELIX 8 8 LEU A 178 ASN A 185 1 8 HELIX 9 9 GLY A 187 GLY A 196 1 10 HELIX 10 10 SER B 2 GLN B 19 1 18 HELIX 11 11 SER B 25 ARG B 102 1 22 HELIX 12 12 ARG B 103 SER B 106 5 4 HELIX 13 13 ASP B 107 LEU B 112 1 6 HELIX 14 14 THR B 118 PHE B 131 1 14 HELIX 15 15 ASN B 136 LYS B 157 1 22 HELIX 16 16 MET B 159 VAL B 161 5 3 HELIX 17 17 LEU B 162 LEU B 178 1 17 HELIX 18 18 LEU B 178 ASN B 185 1 8 HELIX 19 19 GLY B 186 TYR B 195 1 10 HELIX 20 20 SER C 4 GLN C 19 1 16 HELIX 21 21 SER C 25 ARG C 102 1 22 HELIX 22 22 ARG C 103 SER C 106 5 4 HELIX 23 23 ASP C 107 HIS C 113 1 7 HELIX 24 24 THR C 118 ARG C 132 1 15 HELIX 25 25 ASN C 136 LYS C 157 1 22 HELIX 26 26 VAL C 161 LEU C 178 1 18 HELIX 27 27 LEU C 178 ASN C 185 1 8 HELIX 28 28 GLY C 187 GLY C 196 1 10 HELIX 29 29 MET D 1 GLN D 19 1 19 HELIX 30 30 SER D 25 ARG D 102 1 22 HELIX 31 31 ARG D 103 PHE D 105 5 3 HELIX 32 32 ASP D 107 LEU D 112 1 6 HELIX 33 33 THR D 118 PHE D 131 1 14 HELIX 34 34 ASN D 136 LYS D 157 1 22 HELIX 35 35 VAL D 161 LEU D 178 1 18 HELIX 36 36 LEU D 178 ASN D 185 1 8 HELIX 37 37 GLY D 186 TYR D 195 1 10 HELIX 38 38 LEU P 212 GLU P 218 1 7 HELIX 39 39 LEU Q 212 GLU Q 218 1 7 HELIX 40 40 LEU R 212 GLU R 218 1 7 HELIX 41 41 LEU S 212 GLU S 218 1 7 LINK C HT7 P 207 N ILE P 208 1555 1555 1.33 LINK C GLN P 210 N B3E P 211 1555 1555 1.33 LINK C B3E P 211 N LEU P 212 1555 1555 1.33 LINK C ARG P 214 N BIL P 215 1555 1555 1.33 LINK C BIL P 215 N GLY P 216 1555 1555 1.33 LINK C GLU P 218 N 3FB P 219 1555 1555 1.33 LINK C 3FB P 219 N ASN P 220 1555 1555 1.33 LINK C TYR P 222 N B3Y P 223 1555 1555 1.33 LINK C B3Y P 223 N NH2 P 224 1555 1555 1.33 LINK C ILE Q 206 N HT7 Q 207 1555 1555 1.33 LINK C HT7 Q 207 N ILE Q 208 1555 1555 1.33 LINK C GLN Q 210 N B3E Q 211 1555 1555 1.33 LINK C B3E Q 211 N LEU Q 212 1555 1555 1.33 LINK C ARG Q 214 N BIL Q 215 1555 1555 1.33 LINK C BIL Q 215 N GLY Q 216 1555 1555 1.33 LINK C GLU Q 218 N 3FB Q 219 1555 1555 1.33 LINK C 3FB Q 219 N ASN Q 220 1555 1555 1.33 LINK C TYR Q 222 N B3Y Q 223 1555 1555 1.33 LINK C B3Y Q 223 N NH2 Q 224 1555 1555 1.33 LINK C HT7 R 207 N ILE R 208 1555 1555 1.33 LINK C GLN R 210 N B3E R 211 1555 1555 1.33 LINK C B3E R 211 N LEU R 212 1555 1555 1.33 LINK C ARG R 214 N BIL R 215 1555 1555 1.33 LINK C BIL R 215 N GLY R 216 1555 1555 1.33 LINK C GLU R 218 N 3FB R 219 1555 1555 1.33 LINK C 3FB R 219 N ASN R 220 1555 1555 1.33 LINK C TYR R 222 N B3Y R 223 1555 1555 1.33 LINK C B3Y R 223 N NH2 R 224 1555 1555 1.33 LINK C ILE S 206 N HT7 S 207 1555 1555 1.34 LINK C HT7 S 207 N ILE S 208 1555 1555 1.33 LINK C GLN S 210 N B3E S 211 1555 1555 1.33 LINK C B3E S 211 N LEU S 212 1555 1555 1.34 LINK C ARG S 214 N BIL S 215 1555 1555 1.33 LINK C BIL S 215 N GLY S 216 1555 1555 1.33 LINK C GLU S 218 N 3FB S 219 1555 1555 1.33 LINK C 3FB S 219 N ASN S 220 1555 1555 1.33 LINK C TYR S 222 N B3Y S 223 1555 1555 1.33 LINK C B3Y S 223 N NH2 S 224 1555 1555 1.33 CRYST1 80.213 106.290 100.440 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012467 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009408 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009956 0.00000